Home › Pulmonary Arterial Hypertension › New York
Pag-aaral pangklinika para sa Pulmonary Arterial Hypertension sa New York
6 pag-aaral para sa Pulmonary Arterial Hypertension ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA013, Rochester
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- NYU Langone Health, New York
- Westchester Medical Center, Valhalla
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07365332Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- NYU Langone Health, New York
- University of Rochester Medical Center, Rochester
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06274801Pulmonary Hypertension Association Registry
- Weill Cornell Medical Center, New York
- Columbia University Medical Center/NewYork-Presbyterian Hospital, New York
- University of Rochester Medical Center, Rochester
Nagre-recruitObservasyonal na pag-aaral
Edad 0 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Cornell University, New York
- University of Rochester, New York
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2025 · NCT04555161Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Columbia University Medical Center, New York
- Maria Fareri Children's Hospital at WMC Health/Westchester Medical Center, New York
Nagre-recruitObservasyonal na pag-aaral
1 Day – 21 Years · Lahat ng kasarian · Na-update Mar 13, 2025 · NCT02249923Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.